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Little is known about the underlying mechanisms of syncope in heart transplant (HT) 
recipients. Although the graft is typically denervated, neurally mediated reactions have been 
described in these individuals.
1
 Both bradyarrhythmias and tachyarrhythmias may also occur after 
HT, often as a consequence of acute or chronic rejection.
2
 Sudden cardiac death is, indeed, one of 
the leading modes of death in this population.
3 
 
We conducted a retrospective study aimed at addressing the diagnostic yield of implantable 
loop recorders (ILRs) in HT patients who present with syncope of an unknown origin. To the best 
of our knowledge, this clinical issue has never been investigated before, despite the consistent 
evidence that supports the use of ILRs in patients with syncope and a native heart.
4 
 
From January 2006 to December 2016, 22 HT recipients of our programme received an ILR 
after having experienced one or more episodes of syncope (or repetitive presyncope) of which the 
origin remained unexplained after routine diagnostic work‐up. All patients had a left ventricular 
ejection fraction ≥40% and no other clinical indication for prophylactic pacemaker or defibrillator 
implantation.  
 
The mean number of episodes of syncope per patient before ILR implantation was 1.8 ± 1. One 
patient had presented four episodes, seven patients had presented three episodes, and two patients 
had presented two episodes.  
 
Devices implanted were Medtronic Reveal Plus® (n = 8), Medtronic DX® (n = 6), Medtronic 
XT® (n = 1) and Medtronic Linq® (n = 7). Baseline clinical characteristics of study subjects 
before ILR insertion are shown in Table 1.  
  
Table 1. Clinical characteristics of patients at the time of implantable loop recorder insertion 
  
Women, n (%)  5 (23%) 
Age (years) 62 ± 10 
Clinical presentation 
 
Syncope on exertion 9 (41%) 
Prodromal symptoms 9 (41%) 
Two or more episodes of syncope 10 (45%) 
Time elapsed since transplantation (years) 7.6 ± 4.4 
Age of the donor (at transplantation) (years) 38 ± 13 
Coronary allograft vasculopathy 6 (26%) 
Any previous episode of treated graft rejection 7 (32%) 
Left ventricular ejection fraction 
 
≥50% 20 (91%) 
40–49% 2 (9%) 
Baseline 12‐lead electrocardiogram 
 
Sinus rhythm 22 (100%) 
PR interval ≥ 200 ms 2 (9%) 
QTc interval ≥ 440 ms 9 (41%) 
QRS interval ≥ 120 ms 3 (14%) 
Intraventricular conduction abnormalities 6 (27%) 
Left anterior fascicular block 3 (14%) 
Right bundle branch block 2 (9%) 
Right bundle branch block + left anterior fascicular block 1 (5%) 
  
 
Values are numbers and percentage of total (n = 22), or mean ± standard deviation. 
Laboratory tests, 12‐lead electrocardiogram, transthoracic echocardiogram, and 24 h (or 
longer) external electrocardiographic monitoring were performed in all patients before ILR 
insertion. All individuals showed normal sinus rhythm at baseline; only a few minor rhythm 
abnormalities such as frequent premature ventricular beats (in three patients) and paroxysmal, 
night‐time, type I second‐degree atrioventricular block (in one patient) were detected by means of 
this routine diagnostic work‐up.  
 
Coronary angiography was performed in 20 (91%) patients, showing significant (≥50%) 
epicardial coronary disease in six cases. Endomyocardial biopsy was performed in 15 (68%) 
patients, with no evidence of significant acute cellular rejection (grade ≥ 2R) or antibody‐mediated 
rejection (grade AMR ≥1). Only one (5%) patient underwent an electrophysiological study, which 
revealed no significant abnormalities.  
 
Median duration of ILR monitoring was 156 days (range 4–1465 days). Over this period, 11 
(50%) patients experienced at least one episode of relapsing syncope and two (9%) patients died 
suddenly.  
 
The revision of ILR layouts showed clinically relevant bradyarrhythmias in nine patients who 
had relapsing syncope after ILR implantation—paroxysmal third‐degree atrioventricular block in 
four cases, prolonged sinus arrest in four cases, and slow junctional escape rhythm in one case. 
Routine trace review also revealed paroxysmal third‐degree atrioventricular block in one patient 
who remained asymptomatic during follow‐up. All these 10 (45%) patients underwent permanent 
pacemaker implantation, with no further recurrences of syncope after this intervention.  
  
No clinically relevant arrhythmia was detected in the remaining two (9%) patients who 
presented relapsing syncope during ILR monitoring; final presumed diagnosis in both cases was 
neurally mediated syncope. Overall, the cause of syncope was diagnosed on the basis of ILR 
monitoring in 12 (55%) patients, with a median time to diagnosis of 92 days (range 4–1078 days).  
Two (9%) patients died suddenly during ILR monitoring, but, unfortunately, ILR layouts could 
not be reviewed in these individuals. Before ILR insertion, both patients had normal sinus rhythm, 
narrow QRS complex, normal PR and QTc intervals, and preserved left ventricular ejection 
fraction; only one of them had a previous diagnosis of coronary allograft vasculopathy.  
 
In conclusion, this small, retrospective study supports the clinical usefulness of ILR monitoring 
for the evaluation of unexplained syncope in HT recipients. Interestingly, clinically significant 
bradyarrhythmias leading to permanent pacemaker implantation were detected by means of ILR 
monitoring in 45% of patients in our cohort; the overall yield of this strategy to diagnose the cause 
of syncope was 55%, with a median time to diagnosis of 92 days. Unfortunately, 2 out of 22 (9%) 
patients who received the device experienced unexplained sudden death during ILR monitoring.  
 
Larger prospective studies are required to confirm our findings. In the absence of specific 
recommendations, the clinical management of syncope and the prevention of sudden cardiac death 
in HT recipients require an individualized approach.  
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